Dr. Tyndall is a Professor at the UBC School of Population and Public Health and the former Executive Director of the BC Centre for Disease Control. He is an infectious diseases specialist and epidemiologist with an interest in urban health, drug use and drug policy reform. He is an author on over 250 peer-reviewed publications, with a focus on HIV and Hepatitis C care and prevention.

Dr. Schackman is the Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research at Weill Cornell Medical College. He conducts research relating to economic evaluations of the comparative effectiveness of health interventions alongside clinical trials and cohort studies, cost-effectiveness and comparative effectiveness simulation modeling, and implementation science studies—particularly relating to treatment of infectious diseases and substance use disorders.

Evan is a postdoctoral candidate in the Viral Hepatitis Clinical Research Program at the Kirby Institute in Sydney, Australia. His research is focused on the treatment of HCV in high-risk populations including people who inject drugs and prisoners.

Andrew Radley works as a Consultant in Public Health Pharmacy for NHS Tayside. He participates in the work of the Liver Group at the University Of Dundee. He has undertaken a Phd on treating Hepatitis C in community pharmacy settings